TRVI icon

Trevi Therapeutics

36 hedge funds and large institutions have $80.4M invested in Trevi Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
-1
Holders Change %
-2.7%
% of All Funds
0.58%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
11
Reduced
8
Closed
4
Calls
$2K
Puts
$88K
Net Calls
-$86K
Net Calls Change
-$66K
Name Holding Trade Value Shares
Change
Shares
Change %
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$51.2K +$51.2K +27,666 New
B
27
Bailard
California
$39.2K
Bank of New York Mellon
28
Bank of New York Mellon
New York
$26.1K
Two Sigma Investments
29
Two Sigma Investments
New York
$23.9K -$29.1K -15,725 -55%
Charles Schwab
30
Charles Schwab
California
$23.2K
Squarepoint
31
Squarepoint
New York
$21.2K +$21.2K +11,474 New
LPL Financial
32
LPL Financial
California
$18.5K
UBS Group
33
UBS Group
Switzerland
$14K +$8.31K +4,489 +145%
Morgan Stanley
34
Morgan Stanley
New York
$710 -$102 -55 -13%
Wells Fargo
35
Wells Fargo
California
$490 +$7 +4 +2%
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
-$294K -152,300 Closed
VF
37
Virtu Financial
New York
-$27K -13,995 Closed
First Manhattan
38
First Manhattan
New York
-$965 -500 Closed
Bank of America
39
Bank of America
North Carolina
-$178 -92 Closed